Brain Injuries: Clinical Trials

29 trials for Brain Injuries, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 unknown. 29 Phase 2, 7 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 229Unknown 29
Phase 17Unknown 7
Phase 31Unknown 1

Follow Brain Injuries: new trials by email Literature Review of Brain Injuries trials Research Report on Brain Injuries

Trials (filtered) newest first · largest first

All 29 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Effect of Tranexamic Acid on the Clinical Outcomes in Patients With Traumatic Brain Injury
Tranexamic Acid (TXA), Normal saline - Traumatic Brain Injury
Phase 1 / Phase 2UnknownMansoura University902024-03-252024-05-10
Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury
ABX-101 1mg, ABX-101 2mg - Traumatic Brain Injury, Cerebral Edema
Phase 2UnknownAbalonex, LLC452023-12-012023-10-23
Acute Concussion and Melatonin
Melatonin 3 MG, Placebo - Concussion, Mild, Concussion, Brain
Phase 2UnknownChildren's National Research Institute2542023-03-012024-02-07
Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain Injury
Bevacizumab - Brain Injuries
Phase 2UnknownSun Yat-Sen Memorial Hospital of Sun Yat-Sen University2042021-11-012022-03-31
To Evaluate the Effect of Glibenclamide in Reducing Brain Edema of TBI
glibenclamide - Traumatic Brain Injury
Phase 1 / Phase 2UnknownBeijing Tiantan Hospital762021-10-222021-12-08
Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury
C1 Inhibitor, Human, Placebo - Traumatic Brain Injury, Trauma, Head
Phase 2UnknownLeiden University Medical Center1062021-02-252021-09-13
Impact of Vitamin C on Biomarkers of Neurologic Injury in Survivors of Cardiac Arrest
Vitamin C, Placebo - Heart Arrest, Out-Of-Hospital, Biomarkers
Phase 2UnknownUniversity Medical Centre Maribor1502020-10-012020-09-24
Growth Hormone Replacement Therapy for Retried Professional Football Players
Growth Hormone, Placebo - TBI (Traumatic Brain Injury), Concussion, Brain
Phase 2UnknownCenter for Neurological Studies422019-10-082023-02-08
Mood Tracker Smartphone App for Management of Emotional Distress After TBI
Mood tracker ratings - Emotional Distress
Phase 2UnknownMemorial Hermann Health System1262019-04-232020-09-02
Autologous Umbilical Cord Blood Treatment of Neonate With CHD
Autlogous UCB infusion - Congenital Heart Disease, Brain Injuries
Phase 1 / Phase 2UnknownSheba Medical Center602019-02-012021-01-20
Outcomes Mandate National Integration With Cannabis as Medicine
Cannabis, Medical, RYAH-Medtech Inhaler - Chronic Pain, Chronic Pain Syndrome
Phase 2UnknownOMNI Medical Services, LLC2000002018-12-012022-06-02
Fibrinogen Concentrate in Isolated Traumatic Brain Injury
RiaSTAP Injectable Product - Traumatic Brain Injury, Hemorrhage
Phase 1 / Phase 2UnknownLeila Dehghani502018-10-232019-02-27
IL-1ra Dose-range Study for Moderate-to-severe TBI Patients
Anakinra Prefilled Syringe, Isotonic saline - Traumatic Brain INjury
Phase 2UnknownAdel Helmy602017-10-012017-05-08
A Trial Evaluating Effects of COMT Inhibition in Patients With Acquired Brain Injury
Tolcapone 200 MG, Placebo - Brain Injuries, Brain Injuries, Traumatic
Phase 2UnknownSheppard Pratt Health System162017-07-202017-09-06
Autologous Stem Cell Study for Adult TBI (Phase 2b)
Placebo Infusion, Autologous BMMNC Infusion - Brain Injuries, Traumatic, Brain Injuries, Acute
Phase 2UnknownThe University of Texas Health Science Center, Houston372016-11-212024-05-09
The Impact of Riboflavin on Sports-related Concussion
Riboflavin, Placebo - Sports-related Concussion
Phase 2UnknownUniversity of Virginia5002016-08-012017-08-11
A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness
Polypharmacy using FDA-approved products, Median Nerve Stimulation (MNS), Nutraceutical Supplementation - Brain Injury
Phase 1 / Phase 2UnknownInternational Brain Research Foundation302016-03-012016-09-02
Treatment of Bevacizumab Followed by Steroid in RN
Bevacizumab and steroid, Bevacizumab and placebo - Nasopharyngeal Carcinoma, Adverse Effect of Radiation Therapy
Phase 2UnknownSun Yat-Sen Memorial Hospital of Sun Yat-Sen University862016-01-012020-09-17
Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD
Tolcapone - Brain Injuries, Traumatic, Neurocognitive Disorders
Phase 2UnknownSheppard Pratt Health System1002015-11-012017-01-19
Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis
Placebo injection, Botulinum toxin injection, Placebo injection and botulinum toxin injection - Hemiparesis After Stroke, Traumatic Brain Injury
Phase 2UnknownAssistance Publique - Hôpitaux de Paris662014-12-012017-04-19

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Brain Injuries, Traumatic (21)  ·  Brain Concussion (4)  ·  Craniocerebral Trauma (3)  ·  Anxiety Disorders (2)  ·  Depression (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Alzheimer Disease (1)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Anemia, Aplastic (1)  ·  Anemia, Sickle Cell (1)  ·  Angioedemas, Hereditary (1)  ·  Autistic Disorder (1)  ·  Bipolar Disorder (1)  ·  Brain Contusion (1)

Broader conditions

Brain Diseases (29)  ·  Central Nervous System Diseases (29)  ·  Nervous System Diseases (29)  ·  Wounds and Injuries (29)  ·  Trauma, Nervous System (28)  ·  Craniocerebral Trauma (26)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Mental Disorders (6)  ·  Wounds, Nonpenetrating (6)  ·  Head Injuries, Closed (4)  ·  Pathologic Processes (4)  ·  Signs and Symptoms (4)  ·  Brain Damage, Chronic (3)  ·  Cardiovascular Diseases (3)

Interventions

Bevacizumab (2)  ·  Melatonin (2)  ·  Tolcapone (2)  ·  Ascorbic Acid (1)  ·  Botulinum Toxins (1)  ·  Cycloserine (1)  ·  Dexmedetomidine (1)  ·  Epoetin Alfa (1)  ·  Flumazenil (1)  ·  Glyburide (1)  ·  Growth Hormone (1)  ·  Human Growth Hormone (1)  ·  Injections (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  Ketamine (1)

Sponsors

Sheppard Pratt Health System (2)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2)  ·  University of Calgary (2)  ·  University of Virginia (2)  ·  Abalonex, LLC (1)  ·  Abela Pharmaceuticals, Inc. (1)  ·  Adel Helmy (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Beijing Tiantan Hospital (1)  ·  Center for Neurological Studies (1)  ·  Chang Gung Memorial Hospital (1)  ·  Children's National Research Institute (1)  ·  Hadassah Medical Organization (1)  ·  International Brain Research Foundation (1)  ·  Leiden University Medical Center (1)

Countries

United States (11)  ·  China (3)  ·  France (3)  ·  Canada (2)  ·  Israel (2)  ·  Egypt (1)  ·  Iran (1)  ·  Netherlands (1)  ·  Slovenia (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Robert J Schloesser, MD (2)  ·  Adel Helmy, MA, MB BChir, FRCS, PhD (1)  ·  Andrej Markota, MD, PhD, Assist. Prof. (1)  ·  Charles S Cox, MD (1)  ·  David A Zygun, MD, MSc (1)  ·  Dr. Ryan O Lakin, MD JD (1)  ·  Edward C Nemergfut, MD (1)  ·  Guy Rosenthal, MD (1)  ·  Hyo Seop Ahn, M.D, Ph.D (1)  ·  Karen M Barlow, MB.ChB (1)  ·  Philip A Defina, Ph.D. (1)  ·  Randall R Benson, MD (1)  ·  Tang Yamei, Ph.D (1)

Results publications

PMID 23771484, PMID 32217739, PMID 32772826, PMID 34438333, PMID 34863258, PMID 40608439